Aligos Therapeutics (ALGS) vs Tevogen (TVGN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Aligos Therapeutics (ALGS) has outperformed Tevogen (TVGN) over the past year, losing 45.9% versus a loss of 82.5%. Tevogen is the larger company by market cap ($43.5 million vs $33.4 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ALGS | TVGN |
|---|---|---|
| Share price | $5.35 | $6.68 |
| Market cap | $33.41M | $43.50M |
| 1-day change | +0.55% | +2.93% |
| YTD return | -42.92% | -60.79% |
| 1-year return | -45.93% | -82.51% |
| 5-year return | -98.66% | — |
| EPS (TTM) | $-7.41 | $-6.74 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.69 | $39.00 |
| 52-week low | $3.98 | $3.64 |
| Distance from 52-week high | -60.92% | -82.87% |
| Average volume | 91.45K | 9.75K |
| Shares outstanding | 5.44M | 6.51M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ALGS has outperformed TVGN by 36.6 percentage points over the past year.
ALGS vs TVGN FAQ
Which is bigger, Aligos Therapeutics or Tevogen?
Tevogen (TVGN) is larger, with a market capitalization of $43.50M compared with $33.41M for Aligos Therapeutics (ALGS).
Which stock has performed better over the past year, ALGS or TVGN?
ALGS returned -45.93% over the past 12 months, compared with -82.51% for TVGN (price return, excluding dividends). Past performance does not predict future results.
Are Aligos Therapeutics and Tevogen in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.